Redirect Notice
The previous page is sending you to
https://www.businesswire.com/news/home/20200930005106/en/Evaluate-Ltd.-Launches-Evaluate-Omnium-Transforming-Pharma%E2%80%99s-Approach-to-Quantifying-the-Risk-and-Return-of-Novel-Drugs
.
If you do not want to visit that page, you can
return to the previous page
.